This inventor holds 4 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent. Top assignee: Intercept Pharmaceuticals, Inc.. Active years: 2018-2020.
Company Filing History:
Years Active: 2018-2020
Title: Richard Pencek: Innovator in Pharmaceutical Formulations
Introduction
Richard Pencek is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceutical formulations, particularly focusing on obeticholic acid. With a total of 4 patents to his name, Pencek's work has the potential to impact the treatment of various diseases and conditions.
Latest Patents
Pencek's latest patents include innovative formulations of obeticholic acid. These patents detail compositions that offer improved stability, dissolution, and solubility. The methods of preparing these formulations are designed for effective use in treating a range of medical conditions. His work in this area demonstrates a commitment to advancing pharmaceutical science.
Career Highlights
Richard Pencek is currently associated with Intercept Pharmaceuticals, Inc., where he continues to develop groundbreaking pharmaceutical solutions. His expertise in the formulation of obeticholic acid has positioned him as a key player in the industry. Pencek's contributions are recognized for their potential to enhance patient outcomes through improved drug formulations.
Collaborations
Some of Pencek's notable coworkers include Richard Gail Lancaster and Kay Olmstead. Their collaborative efforts contribute to the innovative environment at Intercept Pharmaceuticals, Inc. Together, they work towards advancing pharmaceutical research and development.
Conclusion
Richard Pencek's work in pharmaceutical formulations, particularly with obeticholic acid, showcases his innovative spirit and dedication to improving healthcare. His patents reflect a significant advancement in the field, and his collaborations further enhance the impact of his contributions.